[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100564688":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Endometrial cancer group",null,"Patients diagnosed with endometrial cancer (EC) who underwent surgical staging (total hysterectomy and bilateral salpingo-oophorectomy)",[13],"Other: Endometrial cancer (EC)",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Endometrial cancer (EC)","Endometrial cancer (EC) who underwent surgical staging (total hysterectomy and bilateral salpingo-oophorectomy) Histopathological slides for these cases will be reexamined and staged according to both the Federation of Gynecology and Obestetrics (FIGO) 2009 and updated Federation of Gynecology and Obestetrics (FIGO) 2023 endometrial staging systems. Upstaging refers to reclassification to a higher stage in the FIGO 2023 system compared to Federation of Gynecology and Obestetrics (FIGO)2009, while downstaging is the opposite.\n\nAll patients underwent lymph node dissection except those with Stage IA-Grades I and II endometrioid endometrial cancer and tumor size \\\u003C2 cm.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Yousra H Abdelghafour, MBBCH","CONTACT","00201149264064","yousrahamzawy1997@gmail.com",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Assiut university","RECRUITING","Asyut","71515","Egypt","EG",{"type":34,"coordinates":35},"Point",[36,37],31.18368,27.18096,{"lat":37,"lon":36},[40],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","yousra hassanin abdelghafour","Demonstrator of Pathology, Faculty of Medicine , Assiut University, Assiut, Egypt","100564688","clinicopathological-analysis-of-endometrial-carcinoma-in-the-view-of-old-and-new-international-federation-of-gynecology-and-obestetrics-figo-100564688",false,"NCT06632431","Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)","Inclusion Criteria:\n\n\\- Patients diagnosed with endometrial cancer (EC) who underwent surgical staging (total hysterectomy and bilateral salpingo-oophorectomy) between January 1, 2018, and December 31, 2022 with available medical records since diagnosis and at least follow up 2 years and received adjuvant treatment and available histopathological slides and blocks.\n\nExclusion Criteria:\n\n\\- Patients who received neoadjuvant chemotherapy, had recurrent endometrial cancer, had multiple cancers, lacked histopathological slides and formalin-fixed paraffin-embedded blocks or lacked medical records were excluded","FEMALE","18 Years",{"count":54,"type":55},110,"ESTIMATED","OBSERVATIONAL","Assess the percentage change in stage and risk stratification for patients with endometrial cancer when transitioning from the FIGO 2009 endometrial staging system to the updated FIGO 2023 endometrial staging system.\n\nInvestigate the prognostic impact of the FIGO 2023 endometrial staging system on patient survival.\n\nEvaluate how the shift in stage classification between the FIGO 2009 and FIGO 2023 systems influences adjuvant management decisions for endometrial cancer.",[59,60,61],"Clinicopathological","Endometrial Carcinoma","Federation of Gynecology and Obestetrics","2024-10-10",{"date":64,"type":65},"2024-10-15","ACTUAL",{"date":62,"type":65},{"date":68,"type":55},"2025-10-01",{"name":5,"class":6},1]